| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 01/26/2006 | US20060018914 Novel antibody conjugates reactive with human carcinomas |
| 01/26/2006 | US20060018913 Complex of monoclonal antibodies with label; antitumor agents; anticancer agents |
| 01/26/2006 | US20060018831 TF binding agent and use thereof |
| 01/26/2006 | US20060018830 Gastrin releasing peptide compounds |
| 01/26/2006 | US20060018829 Cellular receptors utilized as carrier agents for pharmaceutical compounds used in tumor imaging and cancer treatment |
| 01/26/2006 | US20060018828 Mixing a sterol or a polyether modified phospholipid capable of forming a liposome with a supercritical carbon dioxide, contacting water-soluble nonionic iodine compound with phospholipid to form a liposome containing vesicles including the iodine compound; chlorine-free solvent |
| 01/26/2006 | US20060018827 Positron therapy of inflammation, infection and disease |
| 01/26/2006 | US20060018826 Biologic modulations with nanoparticles |
| 01/26/2006 | US20060018825 Probe for diseases with amyloid accumulation, amyloid-staining agent, remedy and preventive for diseases with amyloid accumulation and diagnostic probe and staining agent for neurofibrillary change |
| 01/26/2006 | CA2573384A1 Improved n4 chelator conjugates |
| 01/26/2006 | CA2571265A1 Stabilized and lyophilized radiopharmaceutical agents for destroying tumors |
| 01/25/2006 | EP1617876A1 Thorium-227 for use in radiotherapy of soft tissue disease |
| 01/25/2006 | EP1617845A2 Compositions and methods for induction of opioid receptors |
| 01/25/2006 | EP1617819A1 Radioactively marked microparticles, method for the production thereof and use of the same |
| 01/25/2006 | EP1080202B1 Convection-enhanced delivery of aav vectors encoding aadc |
| 01/25/2006 | EP0697872B1 Tricyclopolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents |
| 01/25/2006 | CN1723841A Method for testing organism protein synthesis rate |
| 01/24/2006 | US6989153 Radiation sensitive liposomes |
| 01/24/2006 | US6989139 Matrix metalloproteinase inhibitors |
| 01/24/2006 | US6989138 Synergistic mixture of organosulfer compound and 6-hydroxychroman compound |
| 01/24/2006 | CA2327325C Stimulus sensitive gel with radioisotope and methods of making |
| 01/19/2006 | WO2006007359A1 Anti-mitotic compound |
| 01/19/2006 | WO2005079864A3 Improvement in the ligand protection for mercaptoacetyl triglycine |
| 01/19/2006 | US20060014245 Immunotoxins containing a cytotoxic RNAse fused to the N-terminus of one antibody variable domain prepared and retain the ability to specifically bind antigen; cancer |
| 01/19/2006 | US20060014201 Methods of and kits and compositions for diagnosing colorectal tumors and metastasis thereof |
| 01/19/2006 | US20060013774 Porphyrin compounds and their use in high-field MRI |
| 01/19/2006 | US20060013768 Injection of a radioactive dye for sentinel lymph node identification |
| 01/19/2006 | US20060013767 Virtual colonoscopy with radiolabeled phospholipid ether analogs |
| 01/18/2006 | EP1616883A2 Antibodies against VLA-4 |
| 01/18/2006 | EP1616869A1 Substituted porphyrins and their therapeutic use |
| 01/18/2006 | EP1616182A2 Enzyme replacement therapy with 17-beta-hydroxysteroid dehydrogenase-type 2 |
| 01/18/2006 | EP1615995A2 Morpholino imaging and therapy via amplification targeting |
| 01/18/2006 | EP1615671A1 Microspheres comprising therapeutic and diagnostic radioactive isotopes |
| 01/18/2006 | EP1615668A1 A medicament for the two-step perioperative therapy of solid tumours by radioimmunotherapy |
| 01/18/2006 | CN1723043A 造影剂 Contrast agents |
| 01/18/2006 | CN1723042A Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
| 01/17/2006 | US6987180 Nucleoside phosphate having 5-aminouracil group for incorporation into DNA via treatment with oxidizing agent or alkaline solution which cleaves position of unnatural nucleotide base; polymerase chain reactions |
| 01/17/2006 | US6986891 Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof |
| 01/17/2006 | US6986882 Therapy for functional dyspepsia |
| 01/17/2006 | US6986880 For use in radiology; for attachment to catheters |
| 01/12/2006 | WO2006004736A2 Stable liquid and lyophilized formulation of proteins |
| 01/12/2006 | WO2006004429A2 Imaging agents comprising a non- peptidic vector linked to a fluorophore via a polyethylene glycol linker |
| 01/12/2006 | WO2006003123A2 Radionuclides for medical use |
| 01/12/2006 | WO2005049095A3 Contrast agent imaging angiotensin ii receptors |
| 01/12/2006 | WO2005046449A3 Soluble tcr molecules and methods of use |
| 01/12/2006 | WO2005042766A3 Technetium-99m glucarate methods of use for monitoring tissues |
| 01/12/2006 | US20060008796 Methods for screening cellular proliferation using isotope labels |
| 01/12/2006 | US20060008415 Stable liquid and lyophilized formulation of proteins |
| 01/12/2006 | CA2572707A1 Annexins, derivatives thereof, and annexin-cys variants, as well as therapeutic and diagnostic uses thereof |
| 01/12/2006 | CA2570191A1 Radionuclides for medical use |
| 01/12/2006 | CA2567758A1 Stable liquid and lyophilized formulation of proteins |
| 01/11/2006 | EP1613750A2 Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof |
| 01/11/2006 | EP0827412B1 A method for radiolabeling a somatostatin-derived peptide analogue having one disulfide bond with a radioisotope of rhenium, and their therapeutical applications |
| 01/11/2006 | CN1720050A Improved imaging agents comprising barbituric acid derivatives |
| 01/10/2006 | US6984498 Method of cancer screening primarily utilizing non-invasive cell collection, fluorescence detection techniques, and radio tracing detection techniques |
| 01/10/2006 | US6984373 For diagnosis and therapy of pathological intravascular thrombosis; for detecting, imaging, and localizing thrombi |
| 01/05/2006 | WO2006002122A2 Stabilized and lyophilized radiopharmaceutical agents |
| 01/05/2006 | WO2005074996A3 Lat1 transporter expressed in blood brain barrier cells |
| 01/05/2006 | WO2005070043A3 Methods for treating non-melanoma cancers with paba |
| 01/05/2006 | WO2004078146A3 Trans-membrane-antibody induced inhibition of apoptosis |
| 01/05/2006 | US20060003926 Anticancer, antitumor agents; mixture of metal, drug, peptide and carriers |
| 01/05/2006 | US20060002930 Treatment of disorders |
| 01/05/2006 | US20060002855 Targeted combination immunotherapy of cancer and infectious diseases |
| 01/05/2006 | US20060002854 Conjugate of therapeutic moiety linked to peptide having the amino acid sequence CGKRK, length < 400 residues, or a conservative variant or peptidomimetic; anticarcinogenic, -tumor agents; tissue-targeted therapy; side effect reduction; binds cognate receptor; angiogenesis inhibitors |
| 01/05/2006 | US20060002853 Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 01/05/2006 | US20060002852 Targeted and high density drug loaded polymeric materials |
| 01/05/2006 | US20060002851 Methods for carbon isotope labeling synthesis by transition metal-promoted carbonylation via isocyanate using azides and carbon-isotope monoxide |
| 01/05/2006 | US20060002850 Radiolabeled lymphatic staining agents and methods for making |
| 01/05/2006 | CA2571346A1 Imaging infection with compounds that bind to thymidine kinase |
| 01/05/2006 | CA2570964A1 Stabilized and lyophilized radiopharmaceutical agents |
| 01/04/2006 | EP1610886A1 Method of obtaining gallium-68 and use thereof and device for carrying out said method |
| 01/04/2006 | EP1610835A2 Implantable medical device comprising therapeutic agents with different diffusion rates |
| 01/04/2006 | EP1610818A1 Modified antibodies to prostate-specific membrane antigen and uses thereof |
| 01/04/2006 | EP1610805A2 Thiol-mediated drug attachment to targeting peptides |
| 01/04/2006 | EP1610751A2 Therapeutic agent/ligand conjugate compositions, their methods of synthesis and use |
| 01/04/2006 | EP0932399B1 Water soluble paclitaxel prodrugs |
| 01/04/2006 | CN1234715C Tc N dithiocarbaminate compound ,and its preparation method and use in nuclear medicine |
| 01/04/2006 | CN1234680C Image forming agent, its precursor and preparing process thereof |
| 01/04/2006 | CN1234352C Treatment of PCP addiction and PCP addiction-related behavior |
| 01/03/2006 | US6982271 selective norepinephrine and serotonin reuptake inhibitor (SSNRI); antidepressant; treating cocaine addiction; "N3 bridged" tropanes |
| 01/03/2006 | CA2129755C Stabilized radiopharmaceutical kits |
| 12/29/2005 | WO2005123767A1 Peptide-based compounds |
| 12/29/2005 | WO2005123761A1 GnRH ANALOGS BACKBONE CYCLIZED THROUGH METAL COMPLEXATION |
| 12/29/2005 | WO2005123144A2 System and method for an automated synthesis of gallium-68 generator-based radiopharmaceutical agents |
| 12/29/2005 | WO2005049096A3 Protein and polymer conjugates as chelants with enhanced blood retention |
| 12/29/2005 | WO2004074437A3 Compositions and methods for cancer immunotherapy |
| 12/29/2005 | WO2004005320A3 ErbB-2 RECEPTOR TARGETING PEPTIDE |
| 12/29/2005 | US20050288869 Patient-specific dosimetry |
| 12/29/2005 | US20050288323 Octahydro-indolizine and quinolizine and hexahydro-pyrrolizine |
| 12/29/2005 | US20050287149 Human monoclonal antibodies against bacillus anthracis protective antigen |
| 12/29/2005 | US20050287125 Cell delivery fluid for prevention of cell settling in delivery system |
| 12/29/2005 | US20050287074 Matrix metalloproteinase inhibitors |
| 12/29/2005 | US20050287067 Compounds of the inventions of guanylyl cyclase C |
| 12/29/2005 | US20050287066 Anti-rat angiotensin I-converting enzyme (ACE, CD143) monoclonal antibodies and uses thereof |
| 12/29/2005 | US20050287065 Systems, methods and devices for in vivo monitoring of a localized response via a radiolabeled analyte in a subject |
| 12/29/2005 | DE102005022817A1 Kontrastmittel für ein kombinierte Betriebsarten verwendendes Bildgebungssystem und zugehörige Verfahren und Systeme Contrast agents for a combined modes-use imaging system and associated methods and systems |
| 12/29/2005 | CA2568601A1 Peptide-based compounds |
| 12/28/2005 | EP1609797A1 Compound having affinity with calcified tissue |
| 12/28/2005 | EP1608412A1 Radiolabelled substrates |
| 12/28/2005 | EP1608350A1 Methods of preventing, treating and diagnosing disorders of protein aggregation |